WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
164 hedge funds and large institutions have $2.28B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2013 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 10 closing their positions.
320% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 10
83% more call options, than puts
Call options by funds: $1.87M | Put options by funds: $1.02M
38% more capital invested
Capital invested by funds: $1.65B → $2.28B (+$625M)
29% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 49
24% more funds holding
Funds holding: 132 → 164 (+32)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$26.5M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$25.4M |
| 3 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$23.1M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$18M |
| 5 |
CCAM
Coupland Cardiff Asset Management
London,
United Kingdom
|
+$17.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$38.1M |
| 2 |
JP Morgan Chase
New York
|
-$35.8M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
-$29M |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$25.6M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$20.7M |
WX Hedge Fund Activity: Q4 2013 in Review
164 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2013, worth a combined $2.28B — up 38% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new WX positions and 10 closed out — a net gain of 32 holders — while 63 added to existing stakes and 49 trimmed.
The largest buyer was Mirae Asset Global Investments, adding an estimated $26.5M. The largest seller was Fidelity International, cutting an estimated $38.1M.
- 164 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2013, up from 132 in Q3 2013.
- Funds reported $2.28B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2013, up 38% quarter-over-quarter.
- 42 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2013 and 10 closed out, a net change of +32 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2013 was Mirae Asset Global Investments, an estimated $26.5M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2013 was Fidelity International, an estimated $38.1M sold.
Based on aggregated 13F filings for Q4 2013.